Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amnion Injection for Shoulder OA and Adhesive Capsulitis
NCT03770546Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, single-blind trial of BioD Restore in osteoarthritis (OA) and adhesive capsulitis (AC) (4 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Range of Motion and Strength. Planned start Oct 2021; status: withdrawn.
02
Drugs
BioD Restore
03
Conditions
osteoarthritis (OA)adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT03770546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770546.